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Abstract
The Tat protein of human immunodeficiency virus type 1 (HIV-1) has been shown to restrict premature reverse transcription at late stages
of virus infection and to thus ensure the integrity of the viral RNA genome for packaging. To gain further insights into the roles of Tat in
HIV-1 reverse transcription, we have assessed its effects on the first-strand transfer during the synthesis of minus-strand DNA through use
of a reconstituted cell-free system. The results demonstrated that a form of Tat, containing only the first exon (Tat72), was able to enhance
the first-strand transfer as efficiently as did the viral nucleocapsid protein. Coincidentally, this form of Tat was unable to inhibit the
production of minus-strand strong-stop DNA. Further studies with various mutated forms of Tat showed that its Cys-rich region, rather than
the core and Arg-rich domains, was essential for this strand transfer activity. Moreover, this activity of Tat is largely independent of the TAR
RNA structure. Although full-length Tat protein (Tat86) was also able to promote strand transfer, this activity was limited by a strong overall
inhibition of reverse transcription because of the presence of the second Tat exon. Other nucleic-acid-binding proteins (e.g., single-strand
DNA-binding protein) were employed as negative controls and were unable to promote strand transfer in these assays. We propose that Tat
possesses nucleic acid chaperone activity and can promote the first-strand transfer during HIV-1 reverse transcription; however, these
activities are restricted by the second Tat exon, and the roles of these Tat activities in viral replication remain to be elucidated.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
The reverse transcription of human immunodeficiency
virus type 1 (HIV-1) genomic RNA involves four critical
steps (Telesnitsky and Goff, 1997). The first involves
placement of a cellular tRNALys.3 onto a viral RNA
region of 18 nucleotides (nt), termed the primer-binding
site (PBS). When synthesis of minus-strand DNA reaches
the 5 end of the genome, a first-strand transfer occurs
that is mediated by the 5R and 3R regions as well as by
trans-acting factors such as the viral nucleocapsid (NC)
protein. Next is the generation of a polypurine tract of
RNA that is needed to prime the synthesis of plus-strand
DNA. Finally, a second-strand transfer is required to
complete the synthesis of viral cDNA, and this is medi-
ated by the PBS sequence.
In addition to the reverse transcriptase (RT) enzyme, a
number of viral and cellular proteins have been shown to
participate in reverse transcription, among which NC has
been the most extensively investigated (Darlix et al., 1995).
HIV-1 NC is a small basic protein and contains two CCHC
zinc finger motifs. Because largely of its nucleic acid chap-
erone activity (Rein et al., 1998; Tsuchihashi and Brown,
1994), NC is able to promote the annealing of the tRNALys.3
primer onto the PBS, to increase the processivity of RT, and
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to assist with the first- and second-strand transfers (Darlix et
al., 1995). Aside from NC, viral proteins such as Nef (Aiken
and Trono, 1995; Schwartz et al., 1995), Vif (Von Schwed-
ler et al., 1993), Vpr (Heinzinger et al., 1994), and matrix
(Bukrinsky et al., 1993; Von Schwedler et al., 1994), as well
as several cellular proteins including cyclophilin A (Franke
et al., 1994; Thali et al., 1994), DNA topoisomerase I (Priel
et al., 1990), and ERK2 (Jacque et al., 1998), have also been
reported to modulate reverse transcription through distinct
mechanisms.
In recent years, the Tat protein has also been reported to
play key roles in HIV-1 reverse transcription. Tat was first
recognized as a transactivator of HIV-1 gene transcription.
It recruits the cellular factors cyclin-dependent kinase 9
(CDK9) and cyclin T1 (CynT1) to the transcription elonga-
tion complex and enables CDK9 to hyperphosphorylate the
carboxyl terminus domain of RNA polymerase II (Wei et
al., 1998). It was recently shown that mutations either in Tat
or in the Tat transactivation-responsive element (TAR) were
able to ablate the generation of viral cDNA during infection
(Harrich et al., 1997, 2000; Ulich et al., 1999). Although it
is unknown whether the roles of Tat and TAR in reverse
transcription are related, these studies suggest a novel ac-
tivity of Tat in generation of viral cDNA. Our lab has
developed a reconstituted cell-free assay system to directly
assess the activities of Tat in reverse transcription and
showed that the wild-type two-exon form of the Tat protein
could significantly diminish the generation of minus-strand
strong-stop DNA (()ssDNA) (Kameoka et al., 2001). At
the same time, we have shown that Tat possesses RNA
chaperone activity and can mimic the role of NC in the
placement of the primer of HIV reverse transcription, that
is, tRNAlys3, onto the viral PBS; importantly, different re-
gions of Tat seem to be responsible for these different
activities (Kameoka et al., 2002).
To better understand the roles of Tat in reverse tran-
scription, we have now studied the effects of Tat on the
first-strand transfer during the synthesis of minus-strand
DNA. To pursue this subject, a viral RNA template was
generated that contained the R regions at both the 5 and
the 3 ends; hence, this RNA template can support strand
transfer in both an intra- and an intermolecular fashion.
Since both intra- and intermolecule transfers occur with
similar frequency during reverse transcription within in-
fected cells (Hong et al., 1998; Jones et al., 1994; Van
Wamel and Berkhout, 1998), experiments performed
with this RNA template may approximate the in vivo
situation. Our results show that a truncated form of Tat,
containing only the first exon, that is, one-exon Tat
(Tat72), was able to promote the first-strand transfer
event in reverse transcription as efficiently as the NC
protein. However, this activity was severely limited if the
second-exon of Tat was also present in the context of
full-length Tat protein (Tat86).
Results
Stimulation of the first-strand transfer by HIV-1 Tat72
protein
HIV-1 genomic RNA possesses two identical R regions
at its 5 and 3 ends that mediate both the intra- and the
intermolecule strand transfer events during reverse tran-
scription. The cell-free systems that have been developed to
study strand transfer usually contain two RNA templates
that serve as donors and acceptors and thus permit only the
evaluation of interstrand transfer. To better mimic the in
vivo situation, we have constructed an RNA template,
termed Tp-2, that includes both the 5R and 3R regions as
well as each of the U5 region, the PBS, part of the first-exon
leader sequence, and part of the U3 region (Fig. 1A). This
Tp-2 RNA template allows us to monitor both intra- and
interstrand transfers in a single reaction. Moreover, reverse
transcription performed with this Tp-2 RNA template
yielded higher levels of strand transfer products than that
performed with two other donor and acceptor RNA tem-
plates (data not shown).
Reverse transcription was first initiated from an 18-nt
DNA oligonucleotide that was placed onto the PBS by heat
annealing. The Tp-1 RNA template contains the 5 R, U5,
and PBS and thus only supports the synthesis of ()ssDNA
(Fig. 1A). When reverse transcription was performed with
this RNA template, self-primed cDNA products were seen
when high levels of RT, that is, 200 ng, were employed
(Fig. 1B). In the presence of the Tp-2 RNA template, cDNA
products of 296 nt were observed at the top of the gels when
RT was used at amounts 200 ng, irrespective of the
presence of the self-primed cDNA products (Fig. 1B); this
indicates that strand transfer had occurred. The yield of
strand transfer products did not change with the increase of
RT levels from 200 to 400 ng.
To verify that the DNA band of 296 nt represented a
strand transfer product, reverse transcription was performed
with an RNase H-negative form of HIV-1 RT termed
E478Q (Gotte et al., 1995). Since RNase H degradation of
the RNA template is essential for successful strand transfer
to occur, no strand transfer should take place with use of the
E478Q enzyme. Indeed, only ()ssDNA was synthesized
by E478Q from the Tp-2 RNA template (Fig. 1C). Even
under conditions in which exogenous NC protein was added
to the reactions, no cDNA products longer than ()ssDNA
were seen on the gels. However, when the RNase H enzyme
of Escherichia coli was provided in trans, reverse transcrip-
tion proceeded beyond the stage of ()ssDNA synthesis
and led to the generation of cDNA products longer than
()ssDNA (Fig. 1C). Thus, it is further validated that Tp-2
RNA template was able to support strand transfer.
As stated above, NC has been shown to promote strand
transfer in reverse transcription (Allain et al., 1994; Brule´ et
al., 2000; Darlix et al., 1993; Davis et al., 1998; DeStefano,
1995; Guo et al., 1997, 2000; Kim et al., 1997; Peliska et al.,
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Fig. 1. (A) Depiction of the first-strand transfer during synthesis of minus-strand DNA. The Tp-2 RNA template contains the 5R and 3R regions and is thus
able to support strand transfer in both an intra- and an intermolecular fashion. In addition, this RNA template possesses intact U5 and PBS sequences, a portion
of the noncoding leader region of exon 1 (nt 200 to 263), as well as 24 nt of the U3 sequence. The dashed lines represent RNA fragments that result from
digestion by RT-associated RNase H activity. (B) Synthesis of ()ssDNA and strand transfer DNA (T-DNA) in the presence of various concentrations of
HIV-1 RT. Reverse transcription was primed with DNA oligonucleotides that were annealed onto the PBS. Synthesis of ()DNA was performed at 37°C
for 30 min. The Tp-1 RNA template contains a portion of Tp-2 RNA spanning nt 1 to 262 and thus only supports the generation of ()ssDNA. Synthesis
of T-DNA was generated through use of Tp-2 RNA. Self-priming events occurred in reactions performed with both RNA templates. Lanes 1–4, experiments
performed with 50, 100, 200, and 400 ng of HIV-1 RT. (C) Reverse transcription performed with the Tp-2 RNA template and RNase H-negative HIV-1 RT
E478Q (Gotte et al., 1995). Various amounts of NC protein (i.e., 15, 30, 60, and 90 pmol) were added to stimulate the strand transfer. The RNase H enzyme
(0.2 unit per reaction) from E. coli was provided in trans to compensate for the lost RNase H activity of E478Q. The lengths of the ()ssDNA and T-DNA
products were determined by running DNA sequencing samples in parallel (not shown).
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1994; You and McHenry, 1994). This concept has now been
further tested in experiments performed with our in vitro
strand transfer system. The results of Fig. 2 show that strand
transfer products were not seen in the presence of 50 ng of
RT and absence of exogenous NC or Tat (lane 0). However,
the addition of NC resulted in approximately 20% to 40% of
the ()ssDNA being converted to strand transfer products
(Fig. 2). To test the specificity of this role of NC, single-
strand DNA-binding protein (SSBP) from E. coli was used
in the place of NC in these reactions. However, no strand
transfer products were seen when even 90 pmol of SSBP
was used (Fig. 2). Similarly, negative results were obtained
using human Staufen protein, a well-characterized RNA-
binding protein (Mouland et al., 2000), as an additional
control (data not shown).
Next, we measured the effects of several different forms
of the Tat protein on strand transfer. Strand transfer prod-
ucts were generated when the one-exon form of Tat, that is,
Tat72, was included in the reactions (Fig. 2). Moreover, it
appears that Tat72 was able to stimulate the yield of strand
transfer products to levels comparable to those achieved by
NC protein on a molar basis.
We have previously shown that the two-exon form of
the Tat protein (Tat86), equivalent to wild-type full-
length Tat, was inhibitory to reverse transcription (Ka-
meoka et al., 2001). Consistent with this finding, the
results of Fig. 2 show that Tat86 markedly suppressed
reverse transcription even at the low concentration of 30
pmol, a condition under which NC and Tat72 did not
exert significant inhibitory effects. We then calculated
the relative levels of the strand transfer products versus
those of ()ssDNA; the results show that Tat86 pro-
moted strand transfer at levels similar to Tat72 when
protein concentrations of 15 pmol were used (Fig. 2).
Therefore, both Tat72 and Tat86 are able to stimulate
strand transfer under appropriate conditions, but the abil-
Fig. 2. Effects of NC, Tat86, Tat72, and SSBP on the first-strand transfer. Reverse transcription was performed with DNA primer, 50 ng of HIV-1 RT, and
various concentrations of the aforementioned proteins at 37°C for 30 min. Strand transfer efficiency in each reaction was determined by calculating the
percentage of T-DNA generated relative to total levels of both ()ssDNA and T-DNA. Lane 0, reaction performed with 50 ng of RT alone as a control. Lanes
1–4, experiments conducted with 15, 30, 60, and 90 pmol of NC, Tat86, Tat72, or SSBP. The data of strand transfer were plotted. The gels shown are from
one representative experiment of three experiments that were performed.
Fig. 3. Time-course experiments performed with the Tp-2 RNA template in the presence of either 30 pmol of NC or 30 pmol of Tat72. Reactions were
conducted with 50 ng of HIV-1 RT at 37°C for various times. Control, reactions that were performed without addition of NC or Tat. Time points are labeled
at the bottom of each gel panel. The percentage of T-DNA in each reaction was calculated and plotted as described in the legend to Fig. 2.
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ity of Tat86 to play this role is limited because of its
inhibitory effects on reverse transcription.
Both NC and Tat72 promote strand transfer with similar
kinetics
Next, we compared the abilities of each of NC and Tat72
in time-course experiments to stimulate stand transfer. As
mentioned, virtually no strand transfer occurred when RT
was present alone at a concentration of 50 ng (Fig. 3). In
contrast, strand transfer products were observed 10 min
after the addition of NC or Tat72 to the reactions (Fig. 3).
The efficiency of strand transfer in each case was deter-
mined by calculating the percentage of strand transfer prod-
ucts that were generated (T-DNA) relative to total levels of
both ()ssDNA and T-DNA. The data were then plotted
and reveal that both NC and Tat72 promoted strand transfer
with similar kinetics (Fig. 3).
Tat72 suppresses self-priming from ()ssDNA
When full-length ()ssDNA was generated in the above
reactions, its nascent 3 end was able to reinitiate DNA
synthesis because of the presence of a TAR-like cDNA
structure. This event is termed self-priming, and the result-
ant cDNA product is called self-primed cDNA (Guo et al.,
1997). Self-priming has been shown to interfere with the
first-strand transfer. The NC protein can both prevent self-
priming and increase the efficiency of strand transfer (Guo
et al., 1997). In view of the fact that the Tat72 protein can
also promote strand transfer, we wanted to assess whether
this might be due in part, at least, to a suppression of
self-priming. This issue was first approached through use of
the Tp-1 RNA template that supports only the generation of
()ssDNA. The results show that self-primed cDNA prod-
ucts were seen in reactions performed with 200 ng of HIV-1
RT in the absence of exogenous NC or Tat proteins (Fig. 4,
lane 0). The additional presence of NC protein, even at low
quantities (e.g., 15 pmol), resulted in a sharp decrease in the
amounts of self-primed cDNA products that were generated
(Fig. 4). Tat72 was also able to suppress self-priming but at
higher concentrations in comparison with NC.
These findings were also validated in experiments per-
formed with the Tp-2 RNA template that permits strand
transfer to occur. Again, a dramatic decrease in levels of
self-primed cDNA products was seen in studies performed
with NC, alongside increased levels of strand transfer prod-
ucts (Fig. 4). The addition of Tat72 also suppressed the
self-priming reactions and stimulated strand transfer.
An intact TAR structure is not needed for Tat-mediated
strand transfer
It is known that Tat needs to bind to TAR RNA to exert
its transactivation effects on viral gene transcription. We
wanted to know whether this RNA-binding event was also
required for the positive role of Tat in strand transfer.
Accordingly, we generated a construct termed Tp-3(dU)
that contains a point mutation that changes the TAR bulge
sequence 5-UCU-3 (nt 22–24) to 5-CCU-3 (Fig. 5A);
this mutation has been shown to reduce the affinity of Tat
for TAR (Weeks et al., 1990). The results of our reverse
transcription experiments show that both NC and Tat72
were able to promote strand transfer from this mutated RNA
template at levels comparable to those achieved with the
wild-type RNA template (Fig. 5B).
To further assess the possible involvement of TAR in
this strand transfer activity, a 13-nt segment within TAR (nt
16–28) was removed to generate the mutated RNA template
Tp-3(16–28). The results of Fig. 5B show that both NC and
Tat72 were able to effectively stimulate strand transfer from
this mutant RNA template, although Tat72 was moderately
less efficient than NC in this regard. Therefore, the activity
of both NC and Tat72 in stimulation of strand transfer is
largely TAR-independent.
The Cys-rich domain of Tat72 is essential for its activity
in strand transfer
Tat contains a highly basic Arg-rich motif (ARM) that is
essential for its binding to TAR. In addition, Tat includes a
Fig. 4. Inhibition of self-priming from ()ssDNA by either NC or Tat72
protein. Reverse transcription was performed with 200 ng of HIV-1 RT at
37°C for 60 min with either the Tp-1 or the Tp-2 RNA template. Lane 0,
a control reaction performed with HIV-1 RT alone. Four protein concen-
trations of either NC or Tat72, that is, 15, 30, 60, and 90 pmol (lanes 1–4),
were studied.
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Cys-rich region and a core domain that are both needed for
transactivation of the HIV-1 LTR promoter (Gatignol and
Jeang, 2000). To determine which of these regions of Tat
might be involved in strand transfer, we studied a variety of
mutated forms of Tat in which each of these three regions
was selectively deleted. The mutant Tat proteins thus pro-
duced were termed ARM, Core, and Cys-rich (Fig.
6A). The results of Fig. 6B show that neither the Core nor
the Cys-rich versions of Tat were able to inhibit reverse
transcription at concentrations as high as 60 pmol, similar to
results obtained with Tat72. In contrast, the ARM form of
Tat modestly inhibited reverse transcription at 60 pmol (Fig.
6B). When the efficiency of the first-strand transfer was
measured, the Core and ARM proteins displayed the
same stimulatory effect as Tat72 did (Fig. 6B); in contrast,
the Cys-rich Tat had little or no effect (Fig. 6B). There-
fore, the Cys-rich region of Tat is essential for this strand
transfer activity and the ARM and Core regions play minor
roles in this regard.
Discussion
This study shows that the Tat protein is able to promote
the first-strand transfer during reverse transcription. This
activity was more clearly manifested with the one-exon
form of Tat (Tat72) than with the two-exon form (Tat86),
because the latter can simultaneously exert inhibitory ef-
fects on reverse transcription (Kameoka et al., 2001).
It has long been recognized that Tat is a strong transac-
tivator of viral gene transcription. The Tat protein consists
of special structural elements that include a basic domain, a
core region, and a Cys-rich motif. The basic domain is
required for the specific binding of Tat to TAR RNA, while
the other two regions form part of the transactivation motif
and interact with cellular factors including CDK9 and
CynT1 (Wei et al., 1998; Gatignol and Jeang, 2000). Con-
ceivably, however, these peptide motifs may also allow Tat
to perform other functions than gene transcription, for ex-
ample, its ability to stimulate strand transfer in reverse
transcription in a manner similar to the role played by the
NC protein. This functional homology between Tat and NC
may be due to structural similarities between the two pro-
teins, including the presence of Cys-rich and basic domains.
However, the ability of Tat to stimulate reverse transcription
might also represent a disadvantage for the virus, since any
extensive premature synthesis of cDNA within cells before
virus assembly could lead to degradation of the viral RNA
genome by the RT-associated RNase H activity and thereby
hinder viral RNA packaging. The ability of full-length Tat,
that is, Tat 86, to inhibit reverse transcription (Kameoka et
al., 2001) suggests that the virus may have solved this
problem by including an additional amino acid sequence at
its carboxyl terminus, that is, the second-exon, that helps to
restrict the strand transfer activity. Indeed, the second Tat
exon is nonessential for Tat to transactivate viral gene
expression (Jeang et al., 2001; Jones et al., 1994). The role
of this exon in restriction of reverse transcription is appar-
ently related to its ability to inhibit strand transfer.
In general, strand transfer is mediated by annealing be-
tween homologous nucleic acid sequences. NC possesses
nucleic acid charperone activity (Rein et al., 1998) and is
able to stimulate strand transfer by promoting denaturation
and subsequent binding between complementary stretches
of nucleic acid. In addition, NC contributes to strand trans-
fer by positive regulation of the RNase H activity of RT
(Allain et al., 1994; Peliska et al., 1994; You and McHenry,
1994; Cameron et al., 1997), stabilization of RNA–DNA
heteroduplexes (Driscoll et al., 2001), and inhibition of
self-priming from ()ssDNA (Guo et al., 1997; Jeang et al.,
1999; Driscoll and Hughes, 2000; Lapadat-Tapolsky et al.,
1997; Li et al., 1996). Tat may be able to promote strand
transfer through similar mechanisms. Our results show that
Tat was also able to inhibit self-priming (Fig. 4) and that the
Cys-rich region as well as the basic domain of Tat were
required for the strand transfer activity (Fig. 6). In addition,
Tat can promote annealing between complementary nucle-
otide sequences (unpublished data).
Although many proteins have nucleic-acid-binding prop-
erties, and some can even promote RNA or DNA annealing,
very few have been shown to function in each of primer
tRNALys.3 annealing, RNA dimerization, and strand trans-
fers. Neither viral RTs nor cellular proteins such as E. coli
RecA and human p53 proteins were able to promote HIV-1
RNA dimerization and primer tRNA annealing (Barat et al.,
1989; De Rocquigny et al., 1992; Lapadat-Tapolsky et al.,
1995). Similarly, these experiments show that a SSBP was
not able to assist in strand transfer (Fig. 3) (Kim et al.,
1997). The specificity and efficacy of the HIV-1 NC protein
in these reactions have been attributed to both basic amino
acid residues as well as to zinc finger motifs that have also
been shown to be essential for the first-strand transfer (Guo
et al., 2000). Prions are the only cellular proteins previously
identified that can perform several of the activities charac-
teristic of NC (Gabus et al., 2001a, 2001b), and the biologic
relevance of prions in viral replication is uncertain, although
it is possible that prions may become incorporated into
virions and thereby complement NC in its various roles.
Our data demonstrate that the HIV-1 Tat protein is also
able to stimulate the first-strand transfer during synthesis of
minus-strand DNA. This event involves the unwinding of
two complex and stable nucleic acid structures that are
formed by the TAR RNA sequence and the cDNA sequence
complementary to TAR. The difficulty of transforming
these nucleic acid structures apparently requires both basic
amino acid residues and the zinc finger motifs of NC for the
first-strand transfer, in contrast to the nonrequirement for
the zinc fingers in the annealing of PBS sequences during
the second-strand transfer (Guo et al., 2000). The ability of
Tat to promote the first-strand transfer suggests that Tat
possesses nucleic acid chaperone properties similar to those
of NC, and this feature of Tat may play a role in transacti-
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vation. For example, the binding of Tat to TAR, together
with CynT1 and CDK9, may induce conformational rear-
rangements of TAR that further stabilize the RNA–protein
complex.
The finding reported here that Tat72 can stimulate strand
transfer in reverse transcription is consistent with earlier
reports (Harrich et al., 1997) and helps to resolve an appar-
ent discrepancy in regard to the Tat protein simultaneously
possessing the ability to both positively and negatively
regulate RT activity. As stated, intracellular localization of
various forms of Tat may be an important consideration in
determining temporal relationships between Tat expression
and the role of Tat in regulation of reverse transcription.
It has been widely observed that Tat may not be incor-
porated into progeny virions responsible for a new round of
infection. We have suggested that this exclusion may be
necessary to prevent Tat from being able to play a negative
regulatory role in regard to RT during a subsequent repli-
cation event. At the same time, the negative role of Tat in
regard to RT helps to explain why multiple rounds of
Fig. 5. (A) Illustration of mutations within the TAR region. The RNA
template Tp-3(dU) contains a point mutation that changes the U22 nucle-
otide to a C. The mutant RNA template Tp-3(9–12) is truncated and lacks
a 13-nt RNA fragment, that is, nt 16 to 28. Secondary structures of the
mutant TAR were predicted on the basis of the M-Fold program (Jaeger et
al., 1994; Zuker, 1989). Both the 5 and 3 TAR were mutated accordingly.
(B) Reverse transcription was performed with 50 ng of HIV-1 RT at 37°C
for 30 min. NC or Tat72 protein was used in these reactions at concentra-
tions of either 15 or 60 pmol. The strand transfer efficiency in each reaction
was determined by calculation of the percentage of T-DNA relative to the
sum of both ()ssDNA and T-DNA, and the results are plotted in the
graph. The results shown are from one representative experiment of three
that were performed.
Fig. 6. Mutant Tat proteins and their effects on the first-strand transfer. (A)
Illustration of Tat mutations. Tat72 contains the first exon; the ARM,
Core, and Cys-rich mutants lack the amino acids that span positions 50
to 58, 40 to 47, and 21 to 39, respectively. (B) Reverse transcription was
performed with 50 ng of HIV-1 RT at 37°C for 30 min. Either 15 or 60
pmol of each type of Tat protein was used in the reactions. Lane 0, a
reaction performed with HIV-1 RT alone. The percentage of T-DNA
relative to ()ssDNA and T-DNA was calculated and plotted. The results
shown are from one representative experiment of three that were
performed.
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reverse transcription are not initiated within cells that have
been chronically infected by HIV.
Materials and methods
Plasmid construction
HIV-1 nt sequences from the BH10 infectious cDNA
clone were used in these studies. The vector pSP72 (Pro-
mega, Madison, WI) contains the T7 promoter and was
employed to generate the constructs described below.
Viral cDNA sequences at nt positions 454 to 920 were
first amplified using primer pair P1/P2 (5-GCA GGT
CCT GGC TTA TCG AAA TTA ATA CGA CTC ACT
ATA GGG TCT CTC TGG TTA GAC-3/5-ACG TGG
TAC CAT TAA CTG CGA ATC GTT CTA GC-3); the
PCR products were digested with restriction enzymes
HpaI and KpnI and then inserted into pSP72 to engineer
construct Tp-1. Construct Tp-2 was generated by inser-
tion of the viral cDNA fragment at nt 9516 to 9360 into
construct Tp-1 between the restriction sites BssHII and
PstI (Fig. 1A). A single nucleotide change from U22 to
C22 within the TAR structure was generated by PCR
through use of primer pair P2/P3 (5-GCA CAC GCG
CGC AGC AGC TGC TTT TTG CCT GTA CTG GGT
CTC TCT GGT TAG ACC AGA CCT GAG CC-3). The
construct thus generated was termed Tp-3(dU) (Fig. 5A).
Truncation of the nucleotide sequence from nt 16 to 28
within TAR was generated by PCR using primer pairs
P2/P4 (5-TGC AGG TTA ACC TGG CTT ATC GAA
ATT AAT ACG ACT CAC TAT AGG TCT CTC TGG
TTA GCT GGG AGC TCT CTG GC-3) and P5/P6
(5-CAC CTC AGG TAC CTT TAA GAC-3/5-GCT
TTT TGC CTG TAC TGG GTC TCT CTG GTT AGC
TGG GAG CTC TCT GGC-3). The construct thus gen-
erated was termed Tp-3(16 –28) (Fig. 5A).
Synthesis of RNA templates
RNA was transcribed using a Mega-scripts kit (Am-
bion, Austin, TX). An RNA template of 262 nt was
synthesized from the Tp-1 construct that had been di-
gested with restriction enzyme BssHII. This RNA tem-
plate contained intact R and U5 regions as well as the
PBS and was used for the exclusive synthesis of
()ssDNA. Longer RNA templates were transcribed
from the Tp-2 (Fig. 1A), Tp-3(dU), or Tp-3(16 –28) (Fig.
5A) DNA constructs that had been linearized by diges-
tion with restriction enzyme PstI. These RNA templates
contain both the 5R and the 3R regions and therefore
are competent to support strand transfer. The integrity of
all RNA templates was verified on 5% denaturing poly-
acrylamide gels containing 7 M urea.
RT, Tat, and NC proteins
Recombinant HIV-1 RT (p66/51) was prepared as pre-
viously described (Wohrl et al., 1993). The wild-type form
of the Tat protein (Tat86) as well as various mutated forms,
including Tat72, ARM, Core, and Cys-rich (Fig. 6A),
were produced in E. coli M15 (pREP4) and purified using
nickel–nitrilotriacetic acid resin (Qiagen, Mississauga, On-
tario, Canada) as described (Kameoka et al., 2001). The NC
protein used in this study contains 72 amino acids and was
generated by stepwise solid-phase synthesis (De Rocquigny
et al., 1991). The SSBP was purchased from Promega (St.-
Laurent, Quebec, Canada).
Reverse transcription
An 18-nt DNA oligonucleotide (5-GTCCCTGT-
TCGGGCGCCA-3), complementary to the PBS, was used
as primer in the reactions described below. This DNA oli-
gomer was labeled at the 5 end with 32P (ICN, Irvine, CA)
and was annealed onto RNA template by heating at 85°C for
5 min and a further incubation at 55°C for 10 min (Liang et
al., 1998). Reactions were performed at 37°C in a volume of
20 l containing 1 pmol of RNA template, 1 pmol of
primer, 0.2 mM each dNTPs, 100 ng of RT, 50 mM Tris–Cl
(pH 7.5), 75 mM KCl, 5 mM Mg2Cl, 10 mM DTT, and 10
units of ribonuclease inhibitor (Amersham Pharmacia Bio-
tech., Baie d’Urfe, Quebec, Canada). Various concentra-
tions of NC, Tat, or SSBP proteins were added into the
reaction mixtures to test their effects on strand transfer. The
reaction products were fractionated on 5% denaturing poly-
acrylamide gels containing 7 M urea and visualized by
exposure to X-ray film (Kodak, Rochester, NY).
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